Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs

Acta Psychiatrica Scandinavica
C PatonD Taylor

Abstract

The prevalence of cardiovascular disease in people with schizophrenia is known to be above population norms. In addition, many antipsychotic drugs have been associated with weight gain and some with dyslipidaemia. Our aims were to determine the apparent and actual prevalence of the modifiable risk factors for cardiovascular disease: obesity, hyperlipidaemia and smoking, in hospitalized patients treated with antipsychotic drugs. (i) Survey of clinical notes. (ii) Direct measurement of fasting lipids, body mass index and waist : hip ratio. Lipids were rarely monitored and body weight often not recorded making the apparent prevalence of these cardiovascular risk factors low. Smoking status was recorded. When directly measured, the actual prevalence of obesity was above population norms and two-thirds of patients had a dyslipidaemia. Routine screening for these modifiable risk factors followed by active intervention where appropriate could significantly reduce morbidity and mortality in this patient group.

References

Sep 1, 1992·The American Journal of Psychiatry·D C GoffE Amico
May 1, 1991·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·S C Newman, R C Bland
Jul 1, 1986·Archives of General Psychiatry·P Allebeck, B Wistedt
Jan 4, 1985·JAMA : the Journal of the American Medical Association·D W BlackG Winokur
Jun 1, 1985·Acta Psychiatrica Scandinavica·O H Brook
Oct 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·E Masterson, B O'Shea
Aug 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·P B Mortensen, K Juel
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·S Brown
Jul 11, 1998·The American Journal of Psychiatry·J AddingtonD Addington
Mar 4, 1999·The New England Journal of Medicine·D E JorenbyT B Baker
Apr 1, 1999·Journal of Human Hypertension·L BostN Poulter
Apr 30, 1999·The Journal of Clinical Psychiatry·D B AllisonL J Cheskin
Jul 15, 1999·Psychological Medicine·S BrownC Thompson
Dec 10, 1999·The Journal of Clinical Psychiatry·D N OsserR L Dufresne
Jun 1, 2000·The American Journal of Psychiatry·D C HendersonD C Goff
Jun 27, 2000·Acta Psychiatrica Scandinavica·D M Taylor, R McAskill
Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·S BrownB Barraclough
Jan 16, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J H ThakoreR Reznek
Apr 2, 2002·The American Journal of Psychiatry·Michael J SernyakRobert Rosenheck
May 30, 2002·Life Sciences·Martina C M Ryan, Jogin H Thakore
Jun 8, 2002·Hypertension·Neal L BenowitzPeyton Jacob
Oct 9, 2002·Current Medical Research and Opinion·G ValsamakisS Kumar
Feb 4, 2003·The American Journal of Psychiatry·Bonnie SpringDennis E McChargue
Apr 15, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Andrew C Parrott
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Alan I GreenKimberly Rawlins
Jun 18, 2003·International Journal of Medical Informatics·Steven H BrownRobert M Kolodner
Aug 21, 2003·The Journal of Clinical Psychiatry·Christopher D O'KeefeHoney Weiss
Sep 6, 2003·Acta Psychiatrica Scandinavica·U WernekeS Wessely
Sep 6, 2003·Lancet·Paul Durrington
Sep 6, 2003·Frontiers in Bioscience : a Journal and Virtual Library·Mark F Schumaker

❮ Previous
Next ❯

Citations

Mar 21, 2007·Social Psychiatry and Psychiatric Epidemiology·Christiane RoickMatthias C Angermeyer
Jun 15, 2007·The Australian and New Zealand Journal of Psychiatry·Srinivasan Tirupati, Ling-Ern Chua
May 8, 2007·Schizophrenia Bulletin·Thomas R E BarnesUNKNOWN UK Prescribing Observatory for Mental Health
Oct 3, 2006·International Clinical Psychopharmacology·Maria A RettenbacherW Wolfgang Fleischhacker
Nov 14, 2007·International Journal of Clinical Practice·S SmithG Sullivan
Nov 19, 2011·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·David ScottBrenda Happell
Dec 5, 2006·Quality & Safety in Health Care·Ian D MaidmentCarol Paton
Oct 15, 2010·Journal of Psychopharmacology·Hiram Joseph Wildgust, Mike Beary
Apr 13, 2011·The International Journal of Behavioral Nutrition and Physical Activity·Nick VerhaegheLieven Annemans
Feb 3, 2009·The British Journal of Psychiatry : the Journal of Mental Science·David M TaylorArwel Thomas
Nov 30, 2011·International Journal of Psychiatry in Clinical Practice·Hans RittmannsbergerThomas Zaunmüller
Nov 5, 2010·International Review of Psychiatry·Shubulade Smith
Aug 30, 2012·The Psychiatric Clinics of North America·Christoph U Correll, Juan A Gallego
Aug 3, 2012·Revista de psiquiatrí́a y salud mental·Ramón Mora Ripoll
Sep 29, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·M BernardoUNKNOWN RICAVA Study Group
Jun 15, 2005·Acta Psychiatrica Scandinavica·M Koga, K Nakayama
Jun 28, 2008·Acta Psychiatrica Scandinavica·T R E BarnesUNKNOWN UK Prescribing Observatory for Mental Health
Oct 9, 2007·Acta Psychiatrica Scandinavica·S LeuchtN Sartorius
Jan 25, 2007·Acta Psychiatrica Scandinavica·D C HendersonD C Goff
Sep 14, 2006·Acta Psychiatrica Scandinavica·R KilianK Frasch
Apr 28, 2006·Acta Psychiatrica Scandinavica·F B DickersonL B Dixon
Oct 24, 2007·Acta Psychiatrica Scandinavica. Supplementum·S LevanderE Lindström
Jun 3, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marc De HertChristoph U Correll
Jul 9, 2013·Journal of Clinical Nursing·Brenda HappellChris Platania-Phung
Dec 20, 2011·Acta Psychiatrica Scandinavica·D VancampfortM De Hert
Oct 30, 2010·Scandinavian Journal of Caring Sciences·Karl-Anton ForsbergPer Olof Sandman
Oct 15, 2013·International Journal of Mental Health Nursing·Robert Stanton, Brenda Happell
Sep 30, 2006·International Journal of Nursing Studies·Debbie Robson, Richard Gray
Mar 31, 2012·General Hospital Psychiatry·Jer-Hwa HsuPesus Chou
Jun 24, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kazuhide TanakaShigeto Yamawaki
Jul 9, 2009·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Dang NguyenPhilip Boyce
Jan 21, 2014·The Cochrane Database of Systematic Reviews·Graeme ToshMargueritte M White
Mar 24, 2016·The Cochrane Database of Systematic Reviews·Robert PearsallJohn Geddes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2021 Meta ULC. All rights reserved